A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer

NCT05080842 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
21
Enrollment
INDUSTRY
Sponsor class

Stopped Voluntarily terminate the study since the sponsor's development strategy was adjusted.

Conditions

Interventions

Sponsor

Accutar Biotechnology Inc